Table 2.
Cox Regression Analysis of Predictors of Acute Kidney Injury Among Cohorts of Type 2 Diabetes Patients at Chronic Follow-Up Clinic of University of Gondar Comprehensive Specialized Hospital, from January 1, 2014, to December 31, 2019 (n= 420)
Variables | Survival Status | CHR(95% CI) | Adjusted AHR(95% CI) | |
---|---|---|---|---|
Event | Censored | |||
Residence | ||||
Urban | 55 | 188 | 1.5(0.95, 2.36) | 0.33(0.78, 2.17) |
Rural | 28 | 149 | 1.00 | 1.00 |
Smoking habit | ||||
Never smoker | 10 | 14 | 0.45(0.23, 0.86) | 1.06(0.49, 2.30) |
Smoker | 73 | 323 | 1.00 | 1.00 |
Alcohol use | ||||
Yes | 44 | 88 | 2.746(1.783, 4.23) | 1.60(0.97, 2.65) |
No | 39 | 249 | 1.00 | 1.00 |
Hypertension | ||||
Yes | 73 | 154 | 7.08(3.65, 13.71) | 2.87(1.20, 6.90)* |
No | 10 | 181 | 1.00 | 1.00 |
Congestive heart failure | ||||
Yes | 53 | 52 | 6.61(4.22, 10.37) | 2.89(1.62, 5.13)* |
No | 30 | 285 | 1.00 | 1.00 |
Chronic kidney disease | ||||
Yes | 30 | 8 | 9.03(5.71, 14.27) | 2.92(1.56, 5.48)* |
No | 53 | 329 | 1.00 | 1.00 |
Infection | ||||
Yes | 68 | 175 | 3.71(2.12, 6.50) | 1.82(0.95, 3.52) |
No | 15 | 162 | 1.00 | 1.00 |
Stroke | ||||
Yes | 14 | 19 | 2.71(1.53, 4.82) | 1.85(0.95, 3.58) |
No | 69 | 318 | 1.00 | 1.00 |
Diabetic nephropathy | ||||
Yes | 43 | 25 | 7.13(4.62, 10.99) | 2.04(1.13, 3.68)* |
No | 40 | 312 | 1.00 | 1.00 |
Diabetic ketoacidosis | ||||
Yes | 24 | 62 | 1.83(1.14, 2.95) | 1.58(0.91, 2.73) |
No | 59 | 275 | 1.00 | 1.00 |
Diabetic retinopathy | ||||
Yes | 14 | 20 | 2.27(1.28, 4.04) | 0.80(0.38, 1.67) |
No | 69 | 317 | 1.00 | 1.00 |
Diabetic foot ulcer | ||||
Yes | 26 | 56 | 2.03(1.28, 3.23) | 1.10(0.61, 1.97) |
No | 57 | 281 | 1.00 | 1.00 |
Family history of DM | ||||
Yes | 31 | 81 | 1.84(1.18, 2.88) | 0.79(0.46, 1.36) |
No | 52 | 256 | 1.00 | 1.00 |
Beta blockers | ||||
Yes | 13 | 18 | 2.59(1.43, 4.69) | 1.05(0.53, 2.08) |
No | 70 | 319 | 1.00 | 1.00 |
Calcium channel blocker | ||||
Yes | 41 | 61 | 3.70(2.40, 5.70) | 1.22(0.72, 2.08) |
No | 42 | 276 | 1.00 | 1.00 |
ACE inhibitor/ARBs | ||||
Yes | 51 | 124 | 2.37(1.52, 3.69) | 0.85(0.48, 1.48) |
No | 32 | 213 | 1.00 | 1.00 |
Diuretics | ||||
Yes | 25 | 53 | 1.96(1.22, 3.13) | 0.66(0.37, 1.17) |
No | 58 | 284 | 1.00 | 1.00 |
Aminoglycosides | ||||
Yes | 14 | 21 | 2.24(1.26, 3.97) | 1.14(0.59, 2.22) |
No | 69 | 315 | 1.00 | 1.00 |
NSAIDs | ||||
Yes | 41 | 72 | 2.83(1.84, 4.35) | 1.17(0.64, 2.14) |
No | 42 | 265 | 1.00 | 1.00 |
Statin exposure | ||||
Yes | 53 | 139 | 2.24(1.43, 3.51) | 0.94(0.51, 1.72) |
No | 30 | 197 | 1.00 | 1.00 |
Note: *Significant at p<0.05.